Institutional investors purchased a net $1.9 million shares of ONTY during the quarter ended December 2012, and now own 50.84% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Individual stakeholders | 7.02% |
| Other institutional | 34.60% |
| Mutual fund holders | 16.24% |